KILITCH
Kilitch Drugs (India) Limited
Pharmaceuticals
Share price
₹261
Market cap
₹914 Cr
1Y return
▲ 40%
A pharmaceutical manufacturer engaged in the production and distribution of generic drugs and pharmaceutical formulations across India. Incorporated in 1978, Kilitch Drugs operates across multiple therapeutic segments including cardiovascular, gastrointestinal, respiratory, and anti-infective treatments. The company serves hospitals, clinics, and retail pharmacy channels through its established distribution infrastructure, catering to both domestic markets and institutional healthcare providers.
Investors holding Kilitch Drugs (India) Limited
3.20%
1.34%
Recent moves 2
Indian GovernmentExited
The Indian Government, which previously held a 2.3 percent stake in Kilitch Drugs (India) Limited, is no longer listed among its disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting requirement.
Read more
Dipak Kanayalal ShahDecreased
Dipak Kanayalal Shah decreased his stake in Kilitch Drugs (India) from 3.64% to 3.20% by selling 1,52,500 shares. The sale was valued at ₹2.79 crore, with shares transacting at ₹183.12 apiece.
Read more
Track the whales in Kilitch Drugs (India) Limited
Get alerted the moment a top investor buys or sells.
Get started